The medical device maker misled investors about its position in the electrophysiology market when in reality, demand for those products “had fallen off a cliff,” according to the complaint filed Wednesday in the US District Court for the Southern District of New York.
“Indeed, rather than the Company’s EP business outpacing market growth in the burgeoning EP market, revenue growth from Integer’s ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.